A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Erasca, Inc. (ERAS) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Erasca, Inc. (ERAS) on November 10, 2026 is 15.45 $, −1.06 % on the day. Over 52 weeks the stock traded between 2.10 $ and 24.28 $; the price now sits 60 % of the way up that range. Over the past year the price changed by +587.67 %. Market capitalization is 4.83 billion $, rank 43 among 379 stocks of the same industry with a known capitalization.
Erasca, Inc. trades on Nasdaq under the ticker ERAS. The company belongs to the Health care sector. The trading history on this page starts on 16 July 2021.
Over the past 52 weeks ERAS has traded between 2.11 $ and 24.28 $. As of 10 November 2026 the price stood 60.90% of the way from the 52-week low to the high.
Over one year ERAS shares rose 587.67%; over six months they rose 49.52%. Volatility over 90 days is 65.88%. Dividends are not included: this is price change only, as of 10 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 13.3, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
ERAS has a return on equity of −79.37%, below the sector median of −40.58%. Return on assets is −66.02%, below the sector median of −30.08%.